All News #Library
Biotech
Splisense Receives EMA EARLY PRIME For SPL84 In Cystic Fibrosis
03 Mar 2026 //
PR NEWSWIRE
SpliSense Reveals Phase 2 Success of SPL84 in Cystic Fibrosis
03 Sep 2025 //
PR NEWSWIRE
SpliSense Announces FDA Clearance of IND App for Ph 2 Initiation of SPL84
03 Apr 2024 //
PR NEWSWIRE
SpliSense Successfully Completed Phase 1 Study of SPL84
06 Sep 2023 //
PR NEWSWIRE

Market Place
Sourcing Support